| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.45B | 65.72B | 67.42B | 60.33B | 56.41B | 52.81B |
| Gross Profit | 67.30B | 27.92B | 62.19B | 55.20B | 51.34B | 47.62B |
| EBITDA | 4.15B | 4.79B | 5.88B | 5.16B | 4.54B | 4.06B |
| Net Income | 2.78B | 2.20B | 3.25B | 2.73B | 2.28B | 2.11B |
Balance Sheet | ||||||
| Total Assets | 72.19B | 76.69B | 72.49B | 66.36B | 61.41B | 58.63B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 13.39B | 26.46B | 23.88B | 30.84B | 29.64B |
| Total Debt | 10.00B | 10.11B | 15.05B | 5.00B | 5.00B | 5.00B |
| Total Liabilities | 44.31B | 47.75B | 44.42B | 36.21B | 33.22B | 31.32B |
| Stockholders Equity | 27.88B | 28.94B | 28.07B | 29.90B | 28.18B | 27.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -105.00M | 5.81B | 4.83B | 3.57B | 3.24B |
| Operating Cash Flow | 0.00 | 4.82B | 6.40B | 5.67B | 4.42B | 4.46B |
| Investing Cash Flow | 0.00 | -16.67B | -5.09B | -11.13B | -4.07B | -5.49B |
| Financing Cash Flow | 0.00 | -1.67B | 271.00M | -1.34B | -212.00M | -112.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥6.30T | 7.89 | 16.97% | 2.59% | 21.58% | 19.34% | |
77 Outperform | ¥13.53T | 13.62 | 20.81% | 3.33% | -1.60% | -4.78% | |
74 Outperform | ¥5.49T | 8.29 | ― | 2.82% | ― | ― | |
74 Outperform | ¥56.76B | 8.62 | 6.16% | 1.10% | 4.70% | 44.87% | |
71 Outperform | ¥137.38B | 17.07 | ― | ― | 14.78% | 34.13% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
55 Neutral | ¥90.17B | 40.23 | ― | 0.82% | 8.75% | -28.88% |